Curing Cancer with Patient-First Commitment

Julia, a seasoned software engineer and proficient team leader known for her proactive approach and deep expertise. With a strong background in radiology software development, Julia has honed her skills at industry leaders like Brainlab and Philips before joining P-Cure.

Julia's holds a Bachelor of Applied Science (B.A.Sc.) in Computer Science from the University of Haifa, laying the foundation for her strong career. Her passion for technology and commitment to excellence drive her to deliver innovative solutions and lead teams to success.

Gilbert brings a wealth of expertise and strategic leadership to his role as Chairman of P-Cure, a position he has held since 2019. With a distinguished career spanning renowned global medical technology companies, Gilbert's impact in the field of cancer care is unmatched. Previously serving as Executive Vice President APAC at Elekta, General Manager at both Medtronic and Beckman Instruments in China, and most recently as CEO of Swissray Holdings, Gilbert has consistently driven substantial growth and market leadership across the APAC region, particularly in China.

Widely recognized as a top business leader in cancer care, Gilbert's visionary approach and executive acumen have propelled him to the forefront of the industry. His strategic insights and operational prowess have not only elevated P-Cure's position but have also transformed the landscape of cancer treatment in the APAC region and beyond. With an unwavering commitment to excellence, Gilbert continues to shape the future of cancer care, driving innovation and accessibility to ensure better outcomes for patients worldwide.

Vered is a dedicated clinical research manager at P-Cure, a leading organization specializing in the development and supply of compact proton therapy for cancer treatment. With a profound interest in nuclear physics and armed with a BSc from Ariel University, Vered embarked on a career path in translational science, seamlessly blending her expertise in basic science with clinical research.

Before her current role, Vered honed her skills as a clinical coordinator at Hadassah Medical Center, where she focused extensively on oncology and radiation therapy. She demonstrated a deep commitment to advancing patient care through meticulous research and innovative approaches during her tenure.

Vered's journey underscores her passion for leveraging scientific knowledge to make meaningful contributions to the field of cancer treatment. Her blend of theoretical understanding and hands-on experience positions her as a valuable asset in pursuing cutting-edge therapies to combat cancer effectively.

Ralph serves as the Chief Financial Officer (CFO) of P-Cure, bringing over three decades of extensive expertise in financial management and international finance to the company. Throughout his career, Ralph has held senior financial leadership positions across various sectors, including commercial companies and banking, demonstrating a remarkable track record of success and innovation.

Before assuming his role at P-Cure in 2019, Ralph held the position of Corporate Finance Director at IMI Systems (Elbit), a prominent player in the government defense sector. Prior to that, he served as VP Finance & Treasury at Alvarion Ltd., a telecommunications technology company traded on NASDAQ.

Beyond his professional endeavors, Ralph is actively engaged in promoting international commerce as the Vice President of the Israel Latin America Chamber of Commerce, showcasing his commitment to fostering global partnerships and economic growth. Having moved to Israel from the UK in 1988, Ralph brings a diverse perspective and a deep understanding of cross-cultural dynamics to his role at P-Cure.

With his wealth of experience, unwavering dedication, and proven leadership, Ralph plays a pivotal role in guiding P-Cure towards financial success and sustainable growth, ensuring the company's continued advancement in the dynamic landscape of oncological innovation.

Dr. Michael Marash is the visionary founder and CEO of P-Cure, a pioneering company at the forefront of revolutionizing cancer treatment. Over the past decade, Dr. Marash has spearheaded P-Cure's journey from conceptualization to product commercialization, driving innovation and transforming the landscape of oncological care.

Under his dynamic leadership, P-Cure has forged strategic collaborations with major medical equipment providers such as Philips Medical Systems, expanding the company's reach and impact. Dr. Marash's extensive network within the healthcare industry has facilitated key partnerships with prominent healthcare providers and radiation oncology developers, significantly augmenting the company's pipeline of groundbreaking technologies.

Prior to founding P-Cure, Dr. Marash played a pivotal role in managing technology at Vecta Ltd, a biotech company, where he successfully shepherded multiple gastrointestinal and oncology products through clinical development phases. His earlier contributions to the field include involvement in the development of robotic image-guided diagnostic devices within several high-tech companies, showcasing his versatility and innovation-driven approach.

Dr. Marash's illustrious career is underscored by groundbreaking scientific achievements, with his research published in prestigious peer-reviewed journals. His dedication to advancing medical science is further exemplified by his service in the Medical Troops of the Israeli Defense Force.

Educationally, Dr. Marash holds both an MBA and a Ph.D. degree, obtained from Ben Gurion University and the Weizmann Institute of Science, respectively. His multidisciplinary expertise, entrepreneurial spirit, and unwavering commitment to improving patient outcomes continue to drive P-Cure towards unparalleled success in the fight against cancer.

Udi brings over 15 years of invaluable experience in the high-tech industry to his role as Vice President of Operations at p-cure. With a robust background in production, supply chain management, new product introduction (NPI), and logistics, Udi has consistently demonstrated his expertise in optimizing operational efficiency and driving business success.

Prior to joining P-Cure, Udi held key leadership positions at renowned companies such as Philips, CT, and AMI divisions, where he served as Supply Chain Manager, Plant Manager, and PMO. Before his tenure at Philips, Udi honed his skills in operations management at General Electric (GE) Healthcare, where he embarked on the Operational Management Leadership Program (OMLP), a rigorous two-year program focusing on operational excellence and supply chain strategies.

Udi's academic achievements complement his professional journey, with a Bachelor of Science in Industrial Engineering and a Bachelor of Arts in Economics and Management, both earned from the prestigious Technion Institute of Technology. He further solidified his business acumen by obtaining an MBA from Tel Aviv University.

Driven by a passion for innovation and a relentless pursuit of excellence, Udi is committed to leading P-Cure's operations to new heights, ensuring the company remains at the forefront of the industry.

Ori brings over 26 years of expertise in the Medical Devices Industry to his role as Vice President of Quality and Regulation at P-Cure. With a strong focus on Global Regulatory Affairs, Quality Systems, and Clinical Trials, Ori has consistently demonstrated his ability to navigate complex regulatory landscapes and drive successful processes in organizations of varying sizes, from startups to medium-sized companies.

Throughout his career, Ori has amassed a proven track record of leading teams to meet challenging goals and ensure compliance with regulatory requirements such as FDA, ISO/CE, and regulations in markets including China, Japan, and Korea. His extensive experience in cooperating with international companies and governmental regulators underscores his ability to thrive in diverse and dynamic environments.

With a passion for innovation and a dedication to bringing new and innovative medical devices to market, Ori specializes in startups and fast-growing mid-sized companies. His unique approach focuses on creativity and strategic thinking, enabling organizations to navigate the complexities of regulatory affairs while driving growth and success in the industry.

As Vice President of Quality and Regulation at P-Cure, Ori is committed to upholding the highest standards of quality and regulatory compliance, ensuring that the company continues to lead the way in bringing cutting-edge medical technologies to patients worldwide.

Stephen is a pivotal figure in the advancement of proton therapy, bringing over 30 years of expertise to his role as Marketing Director at P-Cure. With a multifaceted background in governmental affairs, marketing, and public relations, Stephen has been instrumental in the clinical development of proton therapy, shaping its trajectory from concept to reality.

Stephen's journey in proton therapy began with his consultancy work for the first proton center at Loma Linda University Medical Center and the technology transfer from the Department of Energy's Fermi National Accelerator Lab. Throughout his career, he has tirelessly championed proton therapy research and development, leading advocacy campaigns, securing Congressional appropriations, and garnering governmental support to propel the field forward.

As a founding Board member of the National Association of Proton Therapy, Stephen has been at the forefront of shaping the industry's landscape, leveraging his extensive experience as a former Assistant Secretary of the US Department of Energy and strategic planner under three US presidents.

Stephen's consultancy work extends to proton therapy vendors, start-ups, major corporations, and non-profits, where he has provided strategic guidance and prepared business and marketing plans for the development of proton centers worldwide.

With a Bachelor of Science degree from the University of Maryland and a Master of Arts from The American University, Stephen continues to be a driving force in advancing proton therapy, ensuring its accessibility and effectiveness for patients in need.

Dr. Tochner brings unparalleled expertise to P-Cure as a founding member of our Scientific Advisory Board. With a distinguished career spanning decades, Dr. Tochner has played a pivotal role in shaping the landscape of proton therapy.

Currently serving as a professor at the Proton Therapy Center in Singapore, Dr. Tochner leads the development of clinical protocols, ensuring the highest standards of care for patients. His tenure as the Clinical Director of the Proton Therapy Project at the University of Pennsylvania solidified his reputation as a leader in the field, where he spearheaded efforts to identify and address the clinical and technological needs of the center.

Prior to his roles at the University of Pennsylvania, Dr. Tochner held esteemed positions at institutions including the National Cancer Institute's Radiation Oncology Branch and Hadassah University Hospital in Jerusalem, where he served as the Head of the Oncology Department. His extensive experience as a Clinical Director of the University of Pennsylvania's Department of Radiation Oncology and Chief of Neuro-Oncology and Pediatric Radiation Oncology Department further underscores his commitment to advancing cancer treatment.

At P-Cure, Dr. Tochner's guidance and expertise continue to drive innovation, ensuring that our proton therapy solutions remain at the forefront of cancer care.

Dr. Aron Popovtzer is a distinguished member of the P-Cure Scientific Advisory Board, bringing invaluable expertise and insight to the forefront of oncological innovation. Holding a professorship at Hebrew University in Jerusalem and serving as the Director of the Sharett Institute of Oncology at Hadassah Medical Center, Dr. Popovtzer's career is emblematic of a relentless pursuit of excellence in cancer care and research.

A proud alumnus of the Hadassah–Hebrew University School of Medicine, Dr. Popovtzer's foundational medical education was further fortified by three residencies at Rabin Medical Center, where he specialized in Otolaryngology and Head and Neck Cancer, Oncology, and Radiotherapy. His commitment to advancing the field led him to pursue specialized training in Head and Neck Cancer at the University of Michigan and Beth Israel Hospital, New York. Dr. Popovtzer's quest for knowledge also took him to Memorial Sloan Kettering Cancer Center (MSKCC) in New York, where he focused on Radiosurgery, honing his skills in targeted radiation therapies.

With a wealth of experience and expertise, Dr. Popovtzer's contributions to the field of oncology are unparalleled. His dedication to patient care, coupled with his pioneering research endeavors, makes him an invaluable asset to the P-Cure Scientific Advisory Board, driving forward the frontiers of cancer treatment and transforming the lives of patients worldwide.

Prof. Kooy is the Director of Physics at the Francis H. Burr Proton Therapy Center at the Massachusetts General Hospital in Boston, and an Associate Professor of Radiation Therapy at HarvardMedicalSchool. During the last 15 years, Prof. Kooy has led the medical physics development in proton therapy at the center and has become a well recognized scientific figure in the field. His recent book “Proton and Charged Particle Radiotherapy”, written with Tomas F. DeLaney, MD, is a reference textbook for radiotherapy specialists. The F. H. Burr Proton Therapy Center continues the clinical program that commenced at the Harvard Cyclotron Lab in the late ‘60’s where Robert Wilson conceptualized the clinical use of protons in 1947.

Dr. Pfeffer is the Chief of the Radiation Oncology Department at the Chaim Sheba Medical Center in Israel. Like Dr. Tochner, he joined P-Cure right at the beginning and since then he has been acting as a leading clinical consultant. Dr. Pfeffer is a world-renowned specialist in the field of radiation therapy and a talented scientist. His knowledge, experience and scientific creativity allow the company to formulate the best clinically valuable solutions for both oncologists and patients. Dr. Pfeffer completed his medical studies at the University College Hospital Medical School in London and a combined Clinical and Research Fellowship at the Harvard Joint Center for Radiotherapy. Dr. Pfeffer participates in clinical studies with the European Organization for Research and Treatment of Cancer Radiotherapy Group.